Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Biologicals in Treatment of Severe Asthma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* asthma that remains uncontrolled despite moderate to high dose inhaled corticosteroid and additional therapy with at least one other controller medication and need for continuous per oral corticosteroids (OCS) or contraindications (or clinically significant side effects of OCS) against OCS and/or frequent courses (two or more per year) of OCS~Exclusion Criteria:~* patients without asthma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- anti-IL5/IL5R-therapy group (Type: None): Asthma patients, asthma and rhinitis, asthma and nasal polyps and anti-IL5/IL5R
- anti-IgE-therapy group (Type: None): Asthma patients, asthma and rhinitis, asthma and nasal polyps and anti-IgE-therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).